JP2023518262A5 - - Google Patents
Info
- Publication number
- JP2023518262A5 JP2023518262A5 JP2022556196A JP2022556196A JP2023518262A5 JP 2023518262 A5 JP2023518262 A5 JP 2023518262A5 JP 2022556196 A JP2022556196 A JP 2022556196A JP 2022556196 A JP2022556196 A JP 2022556196A JP 2023518262 A5 JP2023518262 A5 JP 2023518262A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- optionally substituted
- cycloalkyl
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062992606P | 2020-03-20 | 2020-03-20 | |
| US62/992,606 | 2020-03-20 | ||
| PCT/US2021/023222 WO2021188938A1 (en) | 2020-03-20 | 2021-03-19 | Phd inhibitor compounds, compositions, and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518262A JP2023518262A (ja) | 2023-04-28 |
| JP2023518262A5 true JP2023518262A5 (https=) | 2024-05-24 |
Family
ID=75639963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556196A Pending JP2023518262A (ja) | 2020-03-20 | 2021-03-19 | Ｐｈｄ阻害剤化合物、組成物、及び使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230159489A1 (https=) |
| EP (1) | EP4121426A1 (https=) |
| JP (1) | JP2023518262A (https=) |
| KR (1) | KR20220156890A (https=) |
| CN (3) | CN121085892A (https=) |
| AR (1) | AR121621A1 (https=) |
| AU (1) | AU2021240044A1 (https=) |
| BR (1) | BR112022018878A2 (https=) |
| CA (1) | CA3176142A1 (https=) |
| CO (1) | CO2022014587A2 (https=) |
| IL (1) | IL296632A (https=) |
| MX (1) | MX2022011392A (https=) |
| PH (1) | PH12022552461A1 (https=) |
| TW (1) | TWI912295B (https=) |
| WO (1) | WO2021188938A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11713298B2 (en) | 2018-05-09 | 2023-08-01 | Akebia Therapeutics, Inc. | Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid |
| WO2021117767A1 (ja) | 2019-12-10 | 2021-06-17 | 田辺三菱製薬株式会社 | 含窒素ヘテロアリールカルボキサミド酢酸誘導体の製造方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663327A (en) * | 1984-05-23 | 1987-05-05 | Bayer Aktiengesellschaft | 1-heteroaryl-4-aryl-pyrazolin-5-ones |
| DE3443308A1 (de) * | 1984-11-28 | 1986-05-28 | Bayer Ag, 5090 Leverkusen | 1-heteroaryl-4-aryl-pyrazolin-5-one zur verwendung als arzneimittel |
| DE102005019712A1 (de) * | 2005-04-28 | 2006-11-09 | Bayer Healthcare Ag | Dipyridyl-dihydropyrazolone und ihre Verwendung |
| DE102006050516A1 (de) * | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte Dihydropyrazolone und ihre Verwendung |
| DE102006050515A1 (de) * | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung |
| DE102006050513A1 (de) * | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substitiuierte Dihydropyrazolone und ihre Verwendung |
| WO2008121861A2 (en) * | 2007-03-28 | 2008-10-09 | Xenon Pharmaceuticals Inc. | Pyrazole and pyrrole compounds useful in treating iron disorders |
| WO2010005851A1 (en) * | 2008-07-08 | 2010-01-14 | Xenon Pharmaceuticals Inc. | Combination therapy for treating iron disorders |
| MA32976B1 (fr) * | 2008-12-29 | 2012-01-02 | Sanofi Sa | Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique comme activateurs de hif |
| CA2894399A1 (en) * | 2012-12-06 | 2014-06-12 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
| EA031647B1 (ru) * | 2013-03-29 | 2019-02-28 | Такеда Фармасьютикал Компани Лимитед | 6-(5-гидрокси-1h-пиразол-1-ил)никотинамидные ингибиторы phd |
| CN106831735B (zh) * | 2017-01-23 | 2019-10-11 | 牡丹江医学院 | 一种治疗骨质疏松的杂环化合物及其制备方法和用途 |
-
2021
- 2021-03-19 EP EP21720874.3A patent/EP4121426A1/en active Pending
- 2021-03-19 JP JP2022556196A patent/JP2023518262A/ja active Pending
- 2021-03-19 MX MX2022011392A patent/MX2022011392A/es unknown
- 2021-03-19 CN CN202511236810.1A patent/CN121085892A/zh active Pending
- 2021-03-19 WO PCT/US2021/023222 patent/WO2021188938A1/en not_active Ceased
- 2021-03-19 PH PH1/2022/552461A patent/PH12022552461A1/en unknown
- 2021-03-19 KR KR1020227036363A patent/KR20220156890A/ko active Pending
- 2021-03-19 AU AU2021240044A patent/AU2021240044A1/en active Pending
- 2021-03-19 TW TW110109980A patent/TWI912295B/zh active
- 2021-03-19 US US17/906,652 patent/US20230159489A1/en active Pending
- 2021-03-19 BR BR112022018878A patent/BR112022018878A2/pt unknown
- 2021-03-19 CA CA3176142A patent/CA3176142A1/en active Pending
- 2021-03-19 CN CN202180034132.4A patent/CN115515948B/zh active Active
- 2021-03-19 CN CN202511236822.4A patent/CN121085893A/zh active Pending
- 2021-03-19 AR ARP210100694A patent/AR121621A1/es unknown
- 2021-03-19 IL IL296632A patent/IL296632A/en unknown
-
2022
- 2022-10-14 CO CONC2022/0014587A patent/CO2022014587A2/es unknown